TALEN

TALEN5-flt4

ID

ZDB-TALEN-150403-7

Name

TALEN5-flt4

Previous Names

None

Target

flt4 (1)

Target Sequence 1

5' - CACAAGAGGAGATCAGAT - 3'

Target Sequence 2

5' - GTTGCTGTACCGTGTTGGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
um200	flt4
um203	flt4

Expression

Gene expression in Wild Types + TALEN5-flt4

No data available

Phenotype

Phenotype resulting from TALEN5-flt4

No data available

Phenotype of all Fish created by or utilizing TALEN5-flt4

Phenotype	Fish	Conditions	Figures
posterior caudal vein vascular sprouts decreased amount, abnormal	flt4^um200/um200	standard conditions	Fig. 3 from Shin et al., 2016
intersegmental vein decreased amount, abnormal	flt4^um200/um200	standard conditions	Fig. 3 from Shin et al., 2016
intersegmental artery increased amount, abnormal	flt4^um200/um200	standard conditions	Fig. 3 from Shin et al., 2016
posterior cardinal vein vascular sprouts Ab2-tek labeling absent, abnormal	flt4^um200/um200	standard conditions	Fig. 3 from Shin et al., 2016
anal fin nucleate erythrocyte accumulation fin vasculature, abnormal	flt4^um203/um203	standard conditions	Fig. 3 from Das et al., 2022
anal fin radial decreased object quality, abnormal	flt4^um203/um203	standard conditions	Fig. 3 from Das et al., 2022
anatomical structure flt4 expression decreased distribution, abnormal	flt4^um203/um203	standard conditions	Fig. 1 from Kok et al., 2015
lymphangiogenic sprout decreased amount, abnormal	flt4^um200/+; y1Tg	standard conditions	Fig. 3 from Shin et al., 2016
thoracic duct lymph vessel development process quality, abnormal	flt4^um200/+; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
thoracic duct lymph vessel development decreased occurrence, abnormal	flt4^um200/+; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
thoracic duct malformed, abnormal	flt4^um200/+; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
otolithic lymph vessel lymph vessel development delayed, abnormal	flt4^um200/um200; nz101Tg	standard conditions	Fig. 7 from Shin et al., 2016
otolithic lymph vessel DsRed expression absent, abnormal	flt4^um200/um200; nz101Tg	standard conditions	Fig. 7 from Shin et al., 2016
lymphangiogenic sprout decreased amount, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 3 from Shin et al., 2016
primordial hindbrain channel malformed, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
primordial hindbrain channel absent, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
thoracic duct lymph vessel development decreased occurrence, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
parachordal vessel absent, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 3 from Shin et al., 2016
posterior cardinal vein endothelial cell ab9-mapk labeling absent, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 4 from Shin et al., 2016
intersegmental vein EGFP expression absent, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 3 from Shin et al., 2016
thoracic duct absent, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
posterior cardinal vein vascular sprouts ab9-mapk labeling absent, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 4 from Shin et al., 2016
primordial hindbrain channel vasculature development decreased occurrence, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
parachordal vessel vasculature development decreased occurrence, abnormal	flt4^um200/um200; y1Tg	standard conditions	Fig. 3 from Shin et al., 2016
medial facial lymph vessel decreased length, abnormal	flt4^um203/um203; nz101Tg	standard conditions	Figure 2 supplement 2. from Gancz et al., 2019
bulbus arteriosus lymphangiogenic sprout decreased amount, abnormal	flt4^um203/um203; nz101Tg	standard conditions	Figure 2 from Gancz et al., 2019
bulbus arteriosus lacks parts or has fewer parts of type bulbus arteriosus lymph vessel, abnormal	flt4^um203/um203; nz101Tg	standard conditions	Figure 2 from Gancz et al., 2019
lymph vasculature DsRed expression decreased amount, abnormal	flt4^um203/um203; nz101Tg/nz101Tg; s843Tg/s843Tg	standard conditions	Fig. 3 from Das et al., 2022
cardiac ventricle lymph vessel absent, abnormal	flt4^um203/um203; nz101Tg; y1Tg	standard conditions	Figure 3 from Gancz et al., 2019
cardiac ventricle has extra parts of type regenerating tissue Collagen, abnormal	flt4^um203/um203; nz101Tg; y1Tg	cryoablation: cardiac ventricle	Figure 7 from Gancz et al., 2019
cardiac ventricle lymph vessel agenesis, abnormal	flt4^um203/um203; nz101Tg; y1Tg	standard conditions	Figure 3 from Gancz et al., 2019
cardiac ventricle regenerating tissue has fewer parts of type cardiac ventricle lymph vessel, abnormal	flt4^um203/um203; nz101Tg; y1Tg	cryoablation: cardiac ventricle	Figure 7 from Gancz et al., 2019
cardiac muscle tissue regeneration disrupted, abnormal	flt4^um203/um203; nz101Tg; y1Tg	cryoablation: cardiac ventricle	Figure 7 from Gancz et al., 2019
cardiac ventricle lacks all parts of type cardiac lymphatic endothelial cluster, abnormal	flt4^um203/um203; nz101Tg; y1Tg	standard conditions	Figure 4 from Gancz et al., 2019
thoracic duct absent, abnormal	flt4^um203/um203; y1Tg	standard conditions	Fig. 1 from Kok et al., 2015
vascular lymphangioblast absent, abnormal	flt4^um203/um203; y1Tg	standard conditions	Fig. 1 from Kok et al., 2015
lymph vessel development disrupted, abnormal	flt4^um203/um203; y1Tg	standard conditions	Fig. 1 from Kok et al., 2015
primordial hindbrain channel absent, abnormal	flt4^um203/um203; y1Tg	standard conditions	Fig. 1 from Kok et al., 2015

Citations